Asia Executives To Watch: Takeda China GM To Depart, Japan Has New MHLW Minister
Executive Summary
Another China GM is leaving. Meanwhile, Japan has a new Minister of Health, Labor and Welfare, and China FDA gets a new deputy commissioner.
You may also be interested in...
Asia Executives To Watch: FDA Names New India Director
FDA has named a new head for India while Roche has appointed a new VP for its anti-infectives and specialty care business unit in China. Personnel changes have also been effected at Bayer, Cook Medical, and the biopharma startup Kira Therapeutics.
Medtechs Must Reflect On China Localization Policies As VBP Expands
China continues to roll out volume-based procurement for medical devices and pharma products and companies should plan their strategies accordingly, advises EY Parthenon’s Hua Su.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.